Psychiatry and Clinical Psychopharmacology, an open-access journal published by AVES since 2017, is dedicated to advancing the fields of psychiatric medicine and psychopharmacology. With an ISSN of 2475-0573 and an E-ISSN of 2475-0581, this journal aims to provide a platform for disseminating innovative research and clinical findings relevant to mental health professionals and researchers. Although it currently holds a Q3 ranking in Pharmacology (medical) and a Q4 ranking in Psychiatry and Mental Health according to the 2023 category quartiles, the journal has established itself as a significant contributor to evolving discussions in these critical fields. Based in the United Kingdom, the journal encompasses diverse topics, ranging from pharmacological treatments to novel therapeutic approaches in psychiatry, thereby appealing to a broad audience of clinicians, scientists, and students. The open-access model ensures that all research is readily available, fostering an environment of collaboration and knowledge-sharing as the journal converges until 2024 to encompass the latest advancements in both pharmacology and clinical psychopharmacology.

JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY is a premier academic journal published by Elsevier Science Inc, dedicated to advancing the fields of child and adolescent psychiatry and developmental psychology. With an impressive impact factor ranking it in the Q1 category of both Developmental and Educational Psychology and Psychiatry and Mental Health, this journal serves as a critical platform for researchers and clinicians seeking to address the mental health challenges faced by younger populations. Since its inception in 1962, it has consistently provided a diverse range of scholarly articles that contribute to evidence-based practices in the field, making it an indispensable resource for the global community. The journal is accessible through various academic databases, ensuring that cutting-edge research reaches those who need it most. As we look ahead to its ongoing trajectory from 1987 to 2024, the JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY continues to be at the forefront of mental health research, fostering innovation and collaboration among professionals and students alike.

The American Journal of Psychiatry, published by the renowned American Psychiatric Publishing, Inc., stands as a premier platform in the field of Psychiatry and Mental Health. With its inaugural edition released in 1945, this esteemed journal has consistently provided a wealth of knowledge, shaping the landscape of psychiatric research and practice globally. Notably, in the latest 2023 Scopus rankings, it achieved an impressive rank of #7 out of 567 journals in its category, placing it in the top 2% percentile, indicative of its substantial impact within the field. The journal is committed to publishing high-quality, peer-reviewed original research, clinical studies, and reviews that advance psychiatric knowledge and treatment options. Although it does not currently offer open access, its contributions are vital for researchers, clinicians, and students dedicated to improving mental health care and understanding complex mental health disorders. As an essential resource, it continues to foster scholarly communication among professionals who are at the forefront of psychiatric science.

JOURNAL OF CLINICAL CHILD AND ADOLESCENT PSYCHOLOGY, published by Routledge Journals, Taylor & Francis LTD, is a premier, peer-reviewed academic journal dedicated to the fields of clinical psychology, developmental, and educational psychology. With an impressive impact factor reflecting its esteemed reputation, this journal is currently ranked Q1 in both Clinical Psychology and Developmental and Educational Psychology categories, showcasing its significant contribution to the advancement of knowledge in these disciplines. Covering a convergence period from 1999 to 2024, it serves as a vital resource for researchers and practitioners seeking to explore innovative interventions, evidence-based practices, and developmental theories relevant to children and adolescents. Accessible from the United States and adhering to rigorous academic standards, this journal invites contributions that facilitate understanding and improvement of psychological health in youth, making it an indispensable tool for professionals dedicated to shaping the future of mental health.

Behaviour Research and Therapy, published by Pergamon-Elsevier Science Ltd, stands as a pivotal journal in the realm of clinical, developmental, and cognitive psychology. With a distinguished history dating back to 1963, this esteemed journal has continuously provided a vital platform for groundbreaking research focused on understanding and treating psychological disorders. It holds an impressive impact factor and is categorized in the Q1 quartile across multiple domains including Clinical Psychology, Developmental and Educational Psychology, Experimental and Cognitive Psychology, and Psychiatry and Mental Health. With its Scopus ranking placing it in the top percentiles of its field, Behaviour Research and Therapy serves as an essential resource for researchers, professionals, and students seeking to remain at the forefront of psychological science. While it operates under a traditional subscription model rather than an open access framework, its contributions are invaluable for advancing our understanding of behavior and therapeutic interventions.

Canadian Journal of Psychiatry-Revue Canadienne de Psychiatrie, published by SAGE Publications Inc, has established itself as a leading voice in the field of psychiatry and mental health since its inception in 1979. With an impact factor that places it in the top quartile (Q1) of its category as of 2023, this journal ranks impressively at #112 out of 567 in the Scopus database, highlighting its significance and influence in the academic community. The journal provides a vital platform for disseminating cutting-edge research, innovative methodologies, and critical reviews, making it an essential resource for researchers, practitioners, and students alike. Although it currently does not offer open access, the journal's commitment to advancing the understanding of psychiatric disorders and mental health issues is unwavering. Situated in Canada, it serves both a national and international audience, fostering collaboration and knowledge sharing across disciplines. As the journal continues to evolve through 2024, it remains dedicated to enhancing the quality of mental health care and promoting the importance of psychiatric research.

Neuropsychopharmacology Reports is a leading open-access journal published by WILEY, dedicated to advancing the fields of clinical psychology, pharmacology, psychiatry, and mental health. Established in 2018, the journal aims to disseminate high-quality research findings, critical reviews, and innovative methodologies that elucidate the complexities of neuropsychopharmacology in enhancing mental health outcomes. With an impressive impact indicated by its Q2 rankings in several categories including Clinical Psychology and Pharmacology (medical) as of 2023, Neuropsychopharmacology Reports stands out as a vital resource for researchers, professionals, and students keen on exploring the interplay between pharmacological interventions and psychological well-being. The journal’s open-access nature ensures that critical advancements in this rapidly evolving field are readily available to a global audience, fostering collaboration and discourse among scholars and practitioners alike. Building on its indexed status with Scopus, the journal is positioned as a noteworthy contributor to ongoing discussions and developments in psychiatry and medical pharmacology.

Frontiers in Psychiatry is a leading journal dedicated to advancing research within the field of psychiatry and mental health. Published by FRONTIERS MEDIA SA, the journal has established a commendable reputation since its inception, reflected in its Q1 status in the 2023 Psychiatry and Mental Health category and a robust ranking of 142 out of 567 in the Scopus database. With an open access model initiated in 2009, Frontiers in Psychiatry aims to disseminate high-quality research to a global audience, fostering collaboration and innovation among researchers, clinicians, and students alike. The journal covers a broad spectrum of topics, including neurobiology, psychosocial factors, treatments, and public health implications of mental disorders, ensuring comprehensive representation of contemporary psychiatric science. Located in Lausanne, Switzerland, and running until 2024, the journal not only emphasizes the importance of mental health research but also encourages interdisciplinary discourse, making it an essential resource for anyone invested in the well-being of individuals and communities alike.

The Scandinavian Journal of Child and Adolescent Psychiatry and Psychology is a premier platform for disseminating significant research in the fields of child and adolescent mental health. Published by SCIENDO, this journal has embraced an Open Access model since 2013, promoting wider accessibility to vital findings and discussions in this pivotal area of study. With a unique focus on issues facing young individuals, it aims to bridge gaps between research, clinical practice, and policy-making. The journal invites submissions from researchers, clinicians, and practitioners worldwide, ensuring a diverse range of perspectives and contributions. By fostering scholarly dialogue and innovation, it plays an essential role in advancing knowledge and improving outcomes in child and adolescent psychiatry and psychology, making it a crucial resource for anyone invested in the mental well-being of young populations.

PSYCHIATRY RESEARCH is a leading journal published by Elsevier Ireland Ltd, dedicated to advancing the field of psychiatry and mental health through the dissemination of rigorous research. With an impressive impact factor and categorized in the top quartile (Q1) of both Biological Psychiatry and Psychiatry and Mental Health in 2023, this journal ranks 14th in the field of Medicine _ Psychiatry and Mental Health out of 567 journals, and 4th in Neuroscience _ Biological Psychiatry out of 51, showcasing its influence and quality. Since its inception in 1979, PSYCHIATRY RESEARCH has provided a platform for innovative studies, clinical trials, and comprehensive reviews aimed at understanding the complexities of mental health disorders. Although it operates under a traditional access model, the journal remains committed to making vital research available to the academic community, ensuring that both seasoned professionals and budding researchers have access to groundbreaking findings. Positioned as a hub for psychiatric research, it caters to a diverse audience including clinicians, psychologists, and students, empowering them to contribute to the evolving landscape of mental health care.